CRISPR Recovery? “Furor” Briefly Snips $500M From Companies’ Values – Xconomy
Undark Magazine |
CRISPR Recovery? “Furor” Briefly Snips $500M From Companies' Values
Xconomy Is the J.P. Morgan CRISPR rollercoaster ride over? As rain fell heavily in San Francisco Monday, the first day of the massive healthcare conference, biotech stocks did, too. At least three of the companies getting drenched could blame a research paper … New Challenges May Lie Ahead for Use of CRISPR in Humans Resistance to Common Germs Poses a Hurdle to New Gene Therapies |
